Attach to Form 990 or Form 990-EZ.
Go to
www.irs.gov/Form990 for the latest information.
| (i) Name of supported organization | (ii) EIN | (iii) Type of organization (described on lines 1- 10 above (see instructions)) | (iv) Is the organization listed in your governing document? | (v) Amount of monetary support (see instructions) | (vi) Amount of other support (see instructions) | |
|---|---|---|---|---|---|---|
| Yes | No | |||||
|
Total |
||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grant.") .. | ||||||
| 2 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf.... | ||||||
| 3 | The value of services or facilities furnished by a governmental unit to the organization without charge.. | ||||||
| 4 | Total. Add lines 1 through 3 | ||||||
| 5 | The portion of total contributions by each person (other than a governmental unit or publicly supported organization) included on line 1 that exceeds 2% of the amount shown on line 11, column (f).. | ||||||
| 6 | Public support. Subtract line 5 from line 4. | ||||||
Calendar year
(or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 7 | Amounts from line 4.. | ||||||
| 8 | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources... | ||||||
| 9 | Net income from unrelated business activities, whether or not the business is regularly carried on.. | ||||||
| 10 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.).. | ||||||
| 11 | Total support. Add lines 7 through 10 | ||||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 1 | Gifts, grants, contributions, and membership fees received. (Do not include any "unusual grants.") . | 280,000 | 299,000 | 386,750 | 796,083 | 860,500 | 2,622,333 |
| 2 | Gross receipts from admissions, merchandise sold or services performed, or facilities furnished in any activity that is related to the organization's tax-exempt purpose | 424,644,834 | 418,954,868 | 415,076,707 | 412,894,240 | 422,094,519 | 2,093,665,168 |
| 3 | Gross receipts from activities that are not an unrelated trade or business under section 513 ..... | 5,802,521 | 7,075,121 | 6,235,464 | 7,848,069 | 7,186,368 | 34,147,543 |
| 4 | Tax revenues levied for the organization's benefit and either paid to or expended on its behalf... | ||||||
| 5 | The value of services or facilities furnished by a governmental unit to the organization without charge | ||||||
| 6 | Total. Add lines 1 through 5 | 430,727,355 | 426,328,989 | 421,698,921 | 421,538,392 | 430,141,387 | 2,130,435,044 |
| 7a | Amounts included on lines 1, 2, and 3 received from disqualified persons | ||||||
| b | Amounts included on lines 2 and 3 received from other than disqualified persons that exceed the greater of $5,000 or 1% of the amount on line 13 for the year. | ||||||
| c | Add lines 7a and 7b.. | ||||||
| 8 | Public support. (Subtract line 7c from line 6.) | 2,130,435,044 | |||||
Calendar year (or fiscal year beginning in) ![]() |
(a) 2014 | (b) 2015 | (c) 2016 | (d) 2017 | (e) 2018 | (f) Total | |
|---|---|---|---|---|---|---|---|
| 9 | Amounts from line 6... | 430,727,355 | 426,328,989 | 421,698,921 | 421,538,392 | 430,141,387 | 2,130,435,044 |
| 10a | Gross income from interest, dividends, payments received on securities loans, rents, royalties and income from similar sources.. | 2,340,045 | 1,980,627 | 1,877,063 | 827,999 | 1,924,522 | 8,950,256 |
| b | Unrelated business taxable income (less section 511 taxes) from businesses acquired after June 30, 1975. | ||||||
| c | Add lines 10a and 10b. | 2,340,045 | 1,980,627 | 1,877,063 | 827,999 | 1,924,522 | 8,950,256 |
| 11 | Net income from unrelated business activities not included in line 10b, whether or not the business is regularly carried on. | ||||||
| 12 | Other income. Do not include gain or loss from the sale of capital assets (Explain in Part VI.) .. | ||||||
| 13 | Total support. (Add lines 9, 10c, 11, and 12.).. | 433,067,400 | 428,309,616 | 423,575,984 | 422,366,391 | 432,065,909 | 2,139,385,300 |
| Section A - Adjusted Net Income | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Net short-term capital gain | 1 | ||||
| 2 | Recoveries of prior-year distributions | 2 | ||||
| 3 | Other gross income (see instructions) | 3 | ||||
| 4 | Add lines 1 through 3 | 4 | ||||
| 5 | Depreciation and depletion | 5 | ||||
| 6 | Portion of operating expenses paid or incurred for production or collection of gross income or for management, conservation, or maintenance of property held for production of income (see instructions) | 6 | ||||
| 7 | Other expenses (see instructions) | 7 | ||||
| 8 | Adjusted Net Income (subtract lines 5, 6 and 7 from line 4) | 8 | ||||
| Section B - Minimum Asset Amount | (A) Prior Year |
(B) Current Year (optional) |
||||
| 1 | Aggregate fair market value of all non-exempt-use assets (see instructions for short tax year or assets held for part of year): | 1 | ||||
| a | Average monthly value of securities | 1a | ||||
| b | Average monthly cash balances | 1b | ||||
| c | Fair market value of other non-exempt-use assets | 1c | ||||
| d | Total (add lines 1a, 1b, and 1c) | 1d | ||||
| e |
Discount claimed for blockage or other factors (explain in detail in Part VI): |
|||||
| 2 | Acquisition indebtedness applicable to non-exempt use assets | 2 | ||||
| 3 | Subtract line 2 from line 1d | 3 | ||||
| 4 | Cash deemed held for exempt use. Enter 1-1/2% of line 3 (for greater amount, see instructions). | 4 | ||||
| 5 | Net value of non-exempt-use assets (subtract line 4 from line 3) | 5 | ||||
| 6 | Multiply line 5 by .035 | 6 | ||||
| 7 | Recoveries of prior-year distributions | 7 | ||||
| 8 | Minimum Asset Amount (add line 7 to line 6) | 8 | ||||
| Section C - Distributable Amount | Current Year | |||||
| 1 | Adjusted net income for prior year (from Section A, line 8, Column A) | 1 | ||||
| 2 | Enter 85% of line 1 | 2 | ||||
| 3 | Minimum asset amount for prior year (from Section B, line 8, Column A) | 3 | ||||
| 4 | Enter greater of line 2 or line 3 | 4 | ||||
| 5 | Income tax imposed in prior year | 5 | ||||
| 6 | Distributable Amount. Subtract line 5 from line 4, unless subject to emergency temporary reduction (see instructions) | 6 | ||||
| Section D - Distributions | Current Year | |
|---|---|---|
| 1 Amounts paid to supported organizations to accomplish exempt purposes | ||
|
2
Amounts paid to perform activity that directly furthers exempt purposes of supported organizations, in excess of income from activity |
||
| 3 Administrative expenses paid to accomplish exempt purposes of supported organizations | ||
| 4 Amounts paid to acquire exempt-use assets | ||
| 5 Qualified set-aside amounts (prior IRS approval required) | ||
| 6 Other distributions (describe in Part VI). See instructions | ||
| 7Total annual distributions. Add lines 1 through 6. | ||
|
8
Distributions to attentive supported organizations to which the organization is responsive (provide details in Part VI). See instructions |
||
| 9 Distributable amount for 2018 from Section C, line 6 | ||
| 10 Line 8 amount divided by Line 9 amount | ||
| Section E - Distribution Allocations (see instructions) |
(i) Excess Distributions |
(ii) Underdistributions Pre-2018 |
(iii) Distributable Amount for 2018 |
|
|---|---|---|---|---|
|
1
Distributable amount for 2018 from Section C, line 6 |
||||
|
2
Underdistributions, if any, for years prior to 2018 (reasonable cause required-- explain in Part VI). See instructions. |
||||
| 3 Excess distributions carryover, if any, to 2018: | ||||
| a From 2013....... | ||||
| b From 2014....... | ||||
| c From 2015....... | ||||
| d From 2016....... | ||||
| e From 2017....... | ||||
| fTotal of lines 3a through e | ||||
| g Applied to underdistributions of prior years | ||||
| h Applied to 2018 distributable amount | ||||
|
i
Carryover from 2013 not applied (see instructions) |
||||
| j Remainder. Subtract lines 3g, 3h, and 3i from 3f. | ||||
| 4Distributions for 2018 from Section D, line 7: | ||||
| $ | ||||
| a Applied to underdistributions of prior years | ||||
| b Applied to 2018 distributable amount | ||||
| c Remainder. Subtract lines 4a and 4b from 4. | ||||
|
5
Remaining underdistributions for years prior to 2018, if any. Subtract lines 3g and 4a from line 2. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
6
Remaining underdistributions for 2018. Subtract lines 3h and 4b from line 1. If the amount is greater than zero, explain in Part VI. See instructions. |
||||
|
7 Excess distributions carryover to 2019. Add lines 3j and 4c. |
||||
| 8 Breakdown of line 7: | ||||
| a Excess from 2014...... | ||||
| b Excess from 2015..... | ||||
| c Excess from 2016..... | ||||
| d Excess from 2017..... | ||||
| e Excess from 2018..... | ||||
| Facts And Circumstances Test |
|---|
| Return Reference | Explanation |
|---|---|
| SUPPLEMENTAL INFORMATION | SCHEDULE A, PART III, TOTAL SUPPORT REFLECTS ALL REVENUES SHOWN,EXCEPT UNRELATED BUSINESS INCOME/LOSS AND ARE RELATED TO THE FOUNDATION'S CORE MISSION DERIVED FROM SUCH ACTIVITIES. |
| Software ID: | |
| Software Version: |
Attach to Form 990 or 990-EZ.
Go to www.irs.gov/Form990 for the latest information.
| Return Reference | Explanation |
|---|---|
| FORM 990 - ORGANIZATION'S MISSION | MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. ("MTF- OR THE "FOUNDATION") IS DEDICATED TO PROVIDING QUALITY ALLOGRAFT TISSUE FOR TRANSPLANTATION THROUGH A COMMITMENT TO EXCELLENCE IN EDUCATION, RESEARCH, RECOVERY, AND CARE FOR RECIPIENTS, DONORS AND THEIR FAMILIES. MTF CONTINUES TO PROMOTE THE HEALTH AND WELFARE OF THE GENERAL PUBLIC BY (1) MAXIMIZING THE AVAILABILITY OF HIGH QUALITY HUMAN TISSUE INCLUDING BONE, DERMAL AND PLACENTAL TISSUE; 2) SUPPORTING MEDICAL, SCIENTIFIC AND OTHER EDUCATIONAL RESEARCH WITH RESPECT TO TISSUE DONATION, RECOVERY AND TRANSPLANTATION; (3) EDUCATING THE GENERAL PUBLIC WITH RESPECT TO THE IMPORTANCE AND BENEFITS OF TISSUE DONATION AND TRANSPLANTATION; AND (4) OTHERWISE PROMOTING TISSUE DONATION THROUGH A COMMITMENT TO EXCELLENCE IN EDUCATION, RESEARCH, RECOVERY AND CARE FOR DONORS, RECIPIENTS, AND THEIR FAMILIES. THE MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. WAS INCORPORATED ON JANUARY 30, 1987, AS A DISTRICT OF COLUMBIA NON-PROFIT MEMBERSHIP ORGANIZATION AND IS A 501(C)(3) ORGANIZATION. THERE IS A CRITICAL NEED FOR MUSCULOSKELETAL, CARDIOVASCULAR, SKIN, PLACENTAL AND OCULAR TISSUE FOR TRANSPLANTATION. IN ORDER TO ACCOMPLISH MTF'S MISSION AND THESE ACTIVITIES, THE FOUNDATION MAINTAINS A DONOR RECOVERY NETWORK, SUPPORTS DONOR AWARENESS PROGRAMS FOR THE PUBLIC, DONATES BONE AND OTHER TISSUE FOR RESEARCH, PROVIDES RESEARCH GRANTS, AND OTHERWISE SUPPORTS BONE, SKIN, WOUNDCARE AND CARDIOVASCULAR TISSUE TRANSPLANTATION, RESEARCH AND EDUCATIONAL PROGRAMS. THE FOUNDATION'S MEMBERSHIP IS COMPRISED OF 501(C)(3) NON-PROIT ORGANIZATIONS. THE MEMBERSHIP CONSISTS OF FIFTY-FIVE ACADEMIC MEMBERS (ORTHOPAEDIC TEACHING INSTITUTIONS), TWENTY-NINE RECOVERY ORGANIZATIONS (ORGAN, EYE AND TISSUE PROCUREMENT ORGANIZATIONS) THROUGHOUT THE UNITED STATES. BIOCON, INC., A NON-PROFIT 501(C)(3) ORGANIZATION, SERVES AS THE SOLE CORPORATE MEMBER OF THE FOUNDATION. THE FOUNDATION MAINTAINS A NATIONWIDE DONOR RECOVERY NETWORK THAT IS BASED ON ITS AFFILIATION WITH ITS RECOVERY AND REFERRING MEMBERS. THIS NATIONAL NETWORK ALLOWS THE PUBLIC TO QUICKLY ACCESS NEEDED ALLOGRAFT TISSUE. BONE AND OTHER ALLOGRAFT TISSUE RECOVERED THROUGH THIS NETWORK IS SUBJECT TO STANDARDIZED SCREENING CRITERIA FOR DONATION ESTABLISHED BY THE FOUNDATION'S MEDICAL BOARD OF TRUSTEES AND DONATION BOARD OF TRUSTEES (DESCRIBED BELOW). THE FOUNDATION ALSO MAINTAINS A QUALITY ASSURANCE PROGRAM WITH RESPECT TO ALLOGRAFT TISSUES RECOVERED THROUGH THE NETWORK. THIS QUALITY PROGRAM IS BASED ON THE POLICIES ADOPTED BY THE AMERICAN ASSOCIATION OF TISSUE BANKS AND THE REGULATIONS PUBLISHED BY THE FOOD & DRUG ADMINISTRATION AND OTHER REGULATORY AGENCIES OUTSIDE THE U.S WHERE THE FOUNDATION DISTRIBUTES TISSUE. THE FOUNDATION PROVIDES RECOVERY ORGANIZATION MEMBERS AND THE GENERAL COMMUNITY THEY SERVE WITH FUNDING FOR HOSPITAL DEVELOPMENT AND DONOR AWARENESS SERVICES. THESE SERVICES ALSO INCLUDE PROVIDING TRAINING TO RECOVERY ORGANIZATION MEMBERS, EDUCATIONAL SYMPOSIUMS TO BOTH RECOVERY ORGANIZATION MEMBERS AND HOSPITAL STAFF, AND EDUCATIONAL MATERIALS FOR USE IN SEMINARS TO HOSPITAL PROFESSIONALS AND THE GENERAL PUBLIC. AS INDICATED IN ARTICLE III OF THE FOUNDATION'S BYLAWS, A MEMBER OF THE FOUNDATION CAN BE AN ACADEMIC MEDICAL INSTITUTION WITH AN ACCREDITED RESIDENCY TRAINNG PROGRAM; A FEDERALLY CHARTERED OPO; OR AN EYE/TISSUE BANK. ALL MEMBERS AGREE TO SUPPORT THE FOUNDATION'S MISSION EITHER THROUGH A SERVICES AND SUPPLY AGREEMENT OR SERVICES AND RECOVERY AGREEMENT. SOME MEMBERS ARE ELIGIBLE FOR RESEARCH FUNDING (SEE SCHED. I, PT. IV FOR GRANT PROGRAM OVERVIEW) FROM THE FOUNDATION UPON RECOMMENDATION AND/OR APPROVAL OF EITHER THE BOARD OF DIRECTORS OR THE MEDICAL BOARD OF TRUSTEES. ALTHOUGH ALL OF THE FOUNDATION'S MEMBERS ARE NON-PROFIT 501(C)(3) ORGANIZATIONS, THE FOUNDATION MAKES ITS TRANSPLANTATION TISSUE NETWORK AND PROGRAMS AVAILABLE TO ANY PERSON OR ORGANIZATION (TYPICALLY THROUGH THEIR HOSPITALS AND PHYSICIANS) IN NEED OF ALLOGRAFT TISSUE. THE FOUNDATION FUNDS ALL COSTS ASSOCIATED WITH THE RECOVERY OF DONOR TISSUES. IT SUPPORTS THESE COSTS WITH FEES INTENDED TO COVER ITS EXPENSES (INCLUDING FUNDING FOR RESEARCH) FROM THE USER OF THE TISSUE. THE FOUNDATION WILL MAKE SUCH TISSUE AVAILABLE AT A REDUCED FEE OR NO CHARGE FOR VARIOUS CAUSES INCLUDING TRANSPLANTATION AND FOR PURPOSES OF RESEARCH BY 501(C)(3) ORGANIZATIONS. ALL FUNDS REALIZED BY THE FOUNDATION ARE USED TO COVER THE COSTS OF ITS PROGRAM ACTIVITIES (INCLUDING OVERHEAD) WITH ANY SURPLUS APPLIED TOWARDS SUBSIDIZING THE COSTS OF THOSE IN NEED OF TISSUE WHO ARE UNABLE TO AFFORD IT, TO FUND EDUCATION AND RESEARCH, TO MAINTAIN THE APPROPRIATE INFRASTRUCTURE AND/OR TO BUILD UP RESERVES NEEDED TO MAINTAIN AND EXPAND THE FOUNDATION'S PROGRAMS. WHILE THE FOUNDATION'S ACTIVITIES ARE MONITORED BY ITS MEMBERS, THE FOUNDATION HAS A TWELVE PERSON BOARD OF DIRECTORS AND TWO NON-VOTING EMERITUS MEMBERS. THIS BOARD IS COMPRISED PRIMARILY OF WORLD RENOWN EXPERTS FROM THE NON-PROFIT HEALTHCARE COMMUNITY HAVING VARIOUS SCIENTIFIC, TRANSPLANT, AND MEDICAL SPECIALTIES. THE BOARD OF DIRECTORS HAS ULTIMATE RESPONSIBILITY TO MANAGE THE FOUNDATION. OF THE BOARD'S 12 VOTING MEMBERS, THERE ARE TWO MEMBERS EACH FROM THE MEDICAL BOARD AND THE DONATION BOARD OF TRUSTEES. SERVING IN TANDEM WITH OTHER BOARD OF DIRECTORS, THE FOUNDATION HAS A MEDICAL BOARD OF TRUSTEES (THE "MEDICAL BOARD") AND A DONATION BOARD OF TRUSTEES ("DONATION BOARD"). THE MEDICAL BOARD IS COMPRISED OF RESPECTIVE PHYSICIANS FROM ORTHOPAEDIC AND PLASTIC SURGERY DEPARTMENTS OF THE ACADEMIC INSTITUTION MEMBERS OF THE FOUNDATION, PLUS ADDITIONAL PERSONS WHO HAVE SPECIFIC EXPERTISE PERTAINING TO TRANSPLANTATION ETHICS AND RESEARCH ACTIVITIES WITHIN THE INDUSTRY. WHILE THE SPECIFIC POWERS AND RESPONSIBILITIES OF THE MEDICAL BOARD ARE DETAILED IN ARTICLE IV, SECTION 2 OF THE FOUNDATION'S BYLAWS, IN GENERAL IT PROVIDES THAT THE MEDICAL BOARD SHALL ADVISE THE FOUNDATION WITH RESPECT TO OPTIMIZING THE DISTRIBUTION OF RESEARCH GRANTS, THE CHOICE OF AREAS MERITING RESEARCH FUNDING, AND ESTABLISHING THE STANDARD POLICIES AND PROTOCOLS RELATING TO THE SCREENING, RECOVERY, TRANSPORT, TESTING, PROCESSING, STORAGE AND DISTRIBUTION OF TRANSPLANTABLE BONE AND TISSUE. THE DONATION BOARD IS COMPRISED OF INDIVIDUALS KNOWLEDGEABLE IN THE FIELD OF TISSUE DONATION AND RECOVERY AND ARE LEADERS OF THE FOUNDATION'S RECOVERY ORGANIZATION MEMBERSHIP. WHILE THE SPECIFIC POWERS AND RESPONSIBILITIES OF THE DONATION BOARD ARE DETAILED IN ARTICLE VI, SECTION 2 OF THE FOUNDATION'S BYLAWS, IN GENERAL THE DONATION BOARD PROVIDES THE BOARD OF DIRECTORS AND SENIOR MANAGEMENT OF THE FOUNDATION WITH RECOMMENDATIONS WITH REGARD TO TISSUE DONATION PRACTICES SUCH AS SCREENING, RECOVERY, AND TESTING CRITERIA. THE FOUNDATION SUPPORTS EDUCATIONAL, SCIENTIFIC AND RESEARCH PROJECTS BY DISTRIBUTING FUNDS AND MAKING AVAILABLE, AT NO CHARGE, DONATED TISSUE FOR RESEARCH. THE FOUNDATION FUNDS MANY TYPES OF PROJECTS RELATED TO ADVANCING TRANSPLANT SCIENCE. ACCORDINGLY, GRANTS ARE PROVIDED FOR PROJECTS IN TISSUE DONATION AND APPLICATION. IN SUM, ALL OF THE ACTIVITIES OF THE FOUNDATION HAVE BEEN AND WILL BE DIRECTED AT MEETING THE NEEDS OF THE GENERAL PUBLIC FOR ALLOGRAFT TISSUE AND/OR IMPROVING THE MANNER IN WHICH TRANSPLANT TISSUE IS MADE AVAILABLE TO THE GENERAL PUBLIC. ADDITIONALLY, THE FOUNDATION SUPPORTS RESEARCH TO ADVANCE THE SCIENCE OF MUSCULOSKELETAL AND OTHER TISSUE APPLICATIONS. THE FOUNDATION OFFERS EDUCATIONAL SERVICE TO SURGEONS AND NURSES BY WAY OF CONTINUING MEDICAL EDUCATION (CME) AND CONTACT HOUR PROGRAMS. IN ADDITION, THE FOUNDATION PROVIDES EDUCATION THROUGH A SPEAKER PROGRAM IN CONJUNCTION WITH ORTHOPAEDIC TEACHING HOSPITALS ACROSS THE UNITED STATES. SURGEONS UTILIZE THE FOUNDATION'S ALLOGRAFT FORMS DURING PROCEDURAL TRAINING OR CADAVERIC SPECIMENS DURING CME COURSES. FINALLY, THE FOUNDATION OFFERS GRANTS TO ITS RECOVERY PARTNERS TO EDUCATE THE PUBLIC AND HEALTHCARE PROFESSIONAL INVOLVED IN THE DONATION PROCESS. |
| FORM 990, PAGE 1, PART I, LINE 6 | DONOR FAMILY SERVICES VOLUNTEER ROLES - CLERICAL: PACKET DEVELOPMENT, PHOTOCOPYING, ASSISTING WITH MAILINGS, ORGANIZING MATERIALS, FILING, PREPARATION AND MAILING OF SYMPATHY, BIRTHDAY AND ANNIVERSARY, AND THINKING OF YOU CARDS, PACKAGING, PREPARATION AND MAILING OF SHAWLS,ETC. DATA ENTRY: SURVEY DATA ENTRY SPECIAL PROJECTS: REVIEW OF MATERIALS, PROGRAM DEVELOPMENT, RESEARCH,PUBLIC RELATIONS, WEB DESIGN AND INFORMATION,NEWSLETTER DESIGN AND INFORMATION, ETC. SPEAKER'S BUREAU: PARTICIPATION WITH MTF STAFF TO EDUCATE THE PUBLIC AND PROFESSIONALS, MEDIA INTERVIEWS, HEALTH FAIRS, ETC. DONOR FAMILY COUNCIL: PARTICIPATION ON COUNCIL WITH OTHER DONOR FAMILIES THROUGH TELEPHONE CALLS, EMAIL, AND OTHER WRITTEN COMMUNICATION FOR THE FOLLOWING: DONOR FAMILY PROGRAM DEVELOPMENT AND IMPLEMENTATION, INCLUDING: FOLLOW-UP BEREAVEMENT PROGRAM FOR FAMILIES, REVIEW PROCESS, REVIEW LETTER AND BROCHURES, REVIEW SURVEYS, REVIEW BEREAVEMENT MATERIALS, ETHICAL ISSUES |
| FORM 990, PAGE 2, PART III, LINE 4A | MUSCULOSKELETAL TRANSPLANT FOUNDATION, INC. (MTF) PROVIDES ALLOGRAFT TISSUES TO THE MEDICAL COMMUNITY.SINCE ITS INCEPTION IN 1987, MTF, THE NATION'S LEADING TISSUE BANK, HAS RECEIVED TISSUE DONATIONS FROM OVER 132,000 DONORS. IN 2018, MTF RECOVERED TISSUE FROM OVER 4,600 DONORS FOR USE IN MUSCULOSKELETAL AND BONE ALLOGRAFT APPLICATIONS, OVER 4,200 DONORS FOR USE IN BURN, GENERAL, AND PLASTIC SURGERY APPLICATIONS, OVER 900 DONORS FOR USE IN WOUNDCARE APPLICATIONS AND OVER 870 DONORS FOR ORGANS AND TISSUES FOR RESEARCH. OVERALL, MTF DISTRIBUTED MORE THAN 450,000 UNITS OF ALLOGRAFT TISSUE DURING 2018. IN ADDITION, MTF DONATED ALLOGRAFT TISSUES FOR RESEARCH, MEDICAL AND EDUCATIONAL PURPOSES. MTF'S RESEARCH AND DEVELOPMENT HAS CONTINUED DEVELOPMENT OF UNIQUE TISSUE FORMS FOR ORTHOPADEDIC AND GENERAL SURGICAL APPLICATIONS. MTF CONTINUES TO SEEK NEW APPLICATIONS FOR THE USE OF THE GIFT OF ALLOGRAFT TISSUES TO RESOLVE UNMET CLINICAL NEEDS AND CONTINUES TO PROVIDE SPECIAL TISSUE FOR RESEARCH PERFORMED BY MEMBERS OF THE ARMED FORCES INSTITUTE OF REGENERATIVE MEDICINE WHICH IS AN ORGANIZATION DEDICATED TO DEVELOPING MEDICAL THERAPIES AND TREATMENTS FOR WOUNDED SOLDIERS. IN 2018, MTF EXPERIENCED CONTINUED GROWTH IN THE SPORTS MEDICINE AND SPINAL ORTHOPAEDICS MARKETS, WOUND CARE AND TREMENDOUS GROWTH IN THE USE OF TISSUE FORMS IN PLASTIC AND RECONSTRUCTIVE SURGERY. HIGHLIGHTS INCLUDE THE INTRODUCTION OF CARTIMAX VIABLE CARTILAGE FIBERS; A READY TO USE, OFF THE SHELF VIABLE CARTILAGE ALLOGRAFT THAT CAN EASILY FILL LESIONS IN THE KNEE, FOOT OR ANKLE, AND FIBERFUSE AND PRIME HD DEMINERALIZED BONE FIBER BASED TISSUE PLATFORMS FOR BONE VOID FILLING APPLICATIONS. IN PLASTIC AND RECONSTRUCTIVE SURGERY, MTF EXPANDED USE OF RENUVA, AN ALLOGRAFT ADIPOSE MATRIX TO TREAT PATIENTS WITH LIPODYSTROPHY, PARRY ROMBERG SYNDROME AND CLEFT PALETTE SOFT TISSUE DEFECTS. MTF ALSO INTRODUCED LIPOGRAFTER, AN AUTOLOGOUS FAT GRAFTING SYSTEM WHICH OFFERS SURGEONS A CONVENIENT, CLOSED SYSTEM TO HARVEST AND REDISTRIBUTE FAT IN THEIR PATIENTS. IN WOUND CARE, MTF CONTINUED TO WORK ON SECURING PATIENT ACCESS THROUGH INSURANCE PROVIDERS AND THE DEVELOPMENT OF INDEPENDENT CLINCAL OUTCOME STUDIES FOR AMNIOBAND AND ALLOPATCH IN THE TREATMENT OF DIABETIC FOOT AND VENOUS LEG ULCERS. MTF CONTINUED ITS SUPPORT (SINCE 2013) OF THE AMERICAN SOCIETY OF PLASTIC SURGEONS (ASPS) AND THE PLASTIC SURGERY FOUNDATION (PSF) IN THE PURSUIT OF RESEARCH TO ADVANCE THE SCIENCE AND APPLICATION OF ALLOGENEIC TISSUE IN PLASTIC AND RECONSTRUCTIVE SURGERY. MTF ALSO CONTINUED PARTICIPATION IN BREAST RECONTRUCTION AWARENESS (BRA) DAY IN OCTOBER, A CAMPAIGN TO SUPPORT BREAST CANCER SURVIVORS' RIGHTS TO MAKE AN INFORMED DECISION WHEN CHOOSING BREAST RECONSTRUCTION OPTIONS. MTF ALSO CONTINUED ITS SUPPORT OF BIOLOGIC RESEARCH GRANTS THROUGH THE PLASTIC SURGERY FOUNDATION (PSF), FULFILLING THE ANNUAL PART OF ITS (2016) FINANCIAL PLEDGE OF 1M OVER FIVE YEARS. IN 2018 MTF FURTHER ENHANCED ITS COMPENDIUM OF CLINCAL STUDIES PROVIDING FOR EXPANDED REIMBURSEMENT COVERAGE FOR TISSUE THERAPIES IN WOUND CARE THROUGHOUT THE UNITED STATES. AMNIOBAND AND ALLOPATCH ALSO ACHIEVED ACCESS STATUS TO THE FEDERAL SUPPLY SCHEDULE (FSS) AND STRATEGIC ACQUISITION CENTER (SAC), THROUGH OUR SERVICE-DISABLED-VETERAN-OWNED SMALL BUSINESS (SDVOSB) PARTNER, ALONG WITH MTF'S BROADER ORTHOPAEDIC TISSUE PORTFOLIO, MAKING TREATMENT OPTIONS AVAILABLE TO PATIENTS WITHIN VERTERANS ADMINISTRATION FACILITIES NATIONALLY. MTF ALSO CONTINUED ITS SUPPORT OF A FIRST EVER PROSPECTIVE RANDOMIZED CLINICAL TRIAL (RCT) FOR THE USE OF ACELLULAR DERMAL MATRIX FOR BREAST RECONSTRUCTION FOLLOWING MASTECTOMY. THE USE OF HUMAN ADM FOR BREAST RECONSTRUCTION HAS BECOME THE STANDARD OF CARE FOR PLASTIC SURGEONS. IN 2017, THE FOUNDATION CONTINUED WITH ITS EFFORTS TO EXPAND ITS FOOTPRINT INTO THE WOUND CARE MARKET WITH ADVANCED WOUND CARE TISSUES. AMNIOBAND VIABLE MEMBRANE WAS LAUNCHED IN 2017 FOR THE TREATMENT OF DIABETIC AND VENOUS ULCERS. IN THE ORTHOPEDIC SPORTS TISSUE MARKET, MTF INTRODUCED A NEW TECHNOLOGY WHICH EXTENDS THE USEFUL LIFE OF FRESH OSTEOCHONDRAL ALLOGRAFTS THEREBY PROVIDING MORE TIME FOR SURGEONS TO MATCH THE GRAFT WITH RECIPIENTS. AND IN PLASTIC AND RESONSTRUCTIVE SURGERY, MTF EXPANDED ITS USE OF RENUVA, AN ALLOGAFT ADIPOSE MATRIX TO TREAT SMALL VOLUME DEFECTS ALONG WITH PROFILE PRE-SHAPED CARTILAGE SEGMENTS FOR RHINEOPLASTY PROCEDURES ELIMINATING THE NEED FOR SURGEONS TO HARVEST A RIB SEGMENT FROM THE PATIENT. FOR INDIVIDUAL STORIES ABOUT DONOR FAMILIES, PLEASE VISIT MTF BIOLOGICS WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/DONORS-FAMILIES. STORIES ABOUT RECIPIENTS ARE ALSO AVAILABLE ON THE WEBSITE AT HTTPS://WWW.MTFBIOLOGICS.ORG/WHO-WE-SERVE/DONORS- COMMUNITY/RECIPIENTS AND ON THE YOUTUBE CHANNEL AT HTTPS://WWW.YOUTUBE.COM/USER/THEMTF1. |
| FORM 990, PAGE 5, PART V, LINE 3B | MTF IS NOT REQUIRED TO FILE FORM 990-T BECAUSE MTF'S GROSS INCOME FROM UNRELATED BUSINESS ACTIVITIES IS LESS THAN 1,000. MTF MAY FILE A FORM 990-T TO ESTABLISH NET OPERATING LOSS AND OTHER CARRY-FORWARDS TO FUTURE YEARS. |
| FORM 990, PART V, LINE 4B | CANADA |
| FORM 990, PAGE 6, PART VI, LINE 6 | MTF IS ORGANIZED WITH TWO CLASSES OF MEMBERSHIP WHICH ARE (1) NON- CORPORATE MEMBERSHIP AND (2) CORPORATE MEMBERSHIP. THE NON-CORPORATE MEMBERS INCLUDE ACADEMIC MEMBERS, RECOVERY MEMBERS AND RESEARCH MEMBERS. THE SOLE CORPORATE MEMBER OF MTF IS BIOCON, INC. |
| FORM 990, PAGE 6, PART VI, LINE 7A | THE SOLE CORPORATE MEMBER MAY APPOINT ALL DIRECTORS SUBJECT TO THE FOLLOWING: THE CURRENT CHAIRPERSON AND VICE CHAIR OF MTF'S "MEDICAL BOARD OF TRUSTEES" WILL BE APPOINTED TO THE BOARD. ALSO, THE CURRENT CHAIRPERSON AND VICE CHAIR OF MTF'S "DONATION BOARD OF TRUSTEES" WILL BE APPOINTED MEMBERS OF THE BOARD OF DIRECTORS. |
| FORM 990, PAGE 6, PART VI, LINE 7B | ANY CHANGES THAT ARE A MATERIAL CHANGE TO THE GOVERNING DOCUMENTS OF THE FOUNDATION (EX.BY-LAWS OR ARTICLES OF INCORPORATION) MUST BE APPROVED BY THE MEMBERS OF THE FOUNDATION'S MEDICAL BOARD OF TRUSTEES AND THE DONATION BOARD OF TRUSTEES. FINAL APPROVAL OF THESE CHANGES MUST BE APPROVED BY THE BOARD OF DIRECTORS. |
| FORM 990, PAGE 6, PART VI, LINE 11B | MEMBERS OF THE AUDIT COMMITTEE OF THE BOARD OF DIRECTORS WERE PROVIDED WITH A PAPER COPY OF FORM 990. THE 990 WAS REVIEWED AT AN OPEN MEETING OF THE AUDIT COMMITTEE. SUBSEQUENT TO MODIFICATIONS, IF ANY, AS A RESULT OF THE AUDIT COMMITTEE MEETING, THE FORM 990 IS THEN CIRCULATED TO ALL MEMBERS OF THE BOARD OF DIRECTORS FOR THEIR FINAL REVIEW AND APPROVAL BEFORE FILING. |
| FORM 990, PAGE 6, PART VI, LINE 12C | MTF SENDS A COMPREHENSIVE QUESTIONNAIRE ANNUALLY TO BOARD MEMBERS, OFFICERS AND KEY EMPLOYEES REQUESTING DISCLOSURE OF ANY CONFLICTS OF INTEREST. |
| FORM 990, PAGE 6, PART VI, LINE 15A | EXECUTIVE COMPENSATION REVIEW: EACH YEAR, MTF REVIEWS AND ASSESSES THE REASONABLENESS OF TOTAL COMPENSATION ARRANGEMENTS FOR OUR EXECUTIVE TEAM, INCLUDING THE CEO. THE ANALYSIS INCORPORATES COMPENSATION SURVEY DATA, FORM 990'S OF COMPANIES OF RELATED INDUSTRIES AND SIMILAR SIZE. A BLEND OF BOTH FOR-PROFIT AND NOT-FOR-PROFIT COMPANIES IS USED. EVERY THIRD YEAR, MTF RETAINS THE SERVICES OF AN INDEPENDENT COMPENSATION CONSULTANT TO ASCERTAIN AND DETERMINE THAT MTF IS PAYING AND PROVIDING A REASONABLE TOTAL COMPENSATION PACKAGE TO THEIR EXECUTIVES AND TO PROVIDE AN OPINION LETTER OF THEIR FINDINGS. COMPENSATION COMMITTEE REVIEW MTF'S BOARD OF DIRECTORS ESTABLISHED A COMPENSATION COMMITTEE IN 1995. THE RESPONSIBILITY OF THE COMMITTEE WAS TO INITIALLY REVIEW AND RECOMMEND TO THE BOARD APPROVAL OF EXECUTIVE AND STAFF COMPENSATION AND CHANGES TO BENEFITS. IN 2000, THE AUTHORITY OF THE COMMITTEE WAS EXPANDED TO INCLUDE THE APPROVAL OF SUCH COMPENSATION AND BENEFITS AND REPORTING SUCH APPROVALS TO THE BOARD. THE COMPENSATION COMMITTEE TYPICALLY MEETS SEMI-ANNUALLY TO REVIEW MERIT AND BONUS RECOMMENDATIONS. A COPY OF THE COMPENSATION COMMITTEE'S CHARTER, AGENDAS, MEETING MATERIALS, AND MEETING MINUTES ARE MAINTAINED. |
| FORM 990, PAGE 6, PART VI, LINE 15B | YES. THE PROCESS IS THE SAME AS DESCRIBED ABOVE IN LINE 15A. |
| FORM 990, PAGE 6, PART VI, LINE 19 | UPON REQUEST, MTF WILL PROVIDE PUBLIC DOCUMENTS THROUGH EMAIL, MAILINGS, OR OFFICE VISITS. |
| FORM 990, PART XI, LINE 9 | GAIN ON INVESTMENT IN BONE BIOLOGICS, INC. 6,690,660 ACCRUED GRANTS -333,544 BOOK /TAX DEPRECIATION DIFFERENCE 1,083,333 TOTAL 7,440,449 |
| Software ID: | |
| Software Version: |